Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride reduces DHT more effectively than finasteride.

Gene variation affects prostate issues and hair loss.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

Finasteride does not prevent bladder cancer.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Berberine may reduce prostate enlargement by blocking inflammation.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Men with enlarged prostates often have more severe baldness.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

No definitive link between finasteride and male breast cancer, but further research is needed.

New treatments targeting fibrosis could improve urinary symptoms in BPH.